Changeflow GovPing Pharma & Drug Safety Lespedeza Extract Skin Radiance Patent
Routine Notice Added Final

Lespedeza Extract Skin Radiance Patent

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Pharma (A61K)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

European Patent Office published patent application EP3681467A2 for Clariant International Ltd covering the use of Lespedeza plant extract as an active ingredient in cosmetic compositions for increasing skin radiance. The patent application was published March 25, 2026, designating multiple European states.

What changed

The EPO published patent application EP3681467A2 for Clariant International Ltd on March 25, 2026, covering the use of Lespedeza plant extract as an active ingredient in compositions for increasing skin radiance. Inventors include YEOM Mi Ji, JUNG Eun Sun, PARK Deok Hoon, FRECHET Mathilde, and CHAJRA Hanane. The patent designates all EU member states plus Switzerland, Norway, Turkey, and other European countries.\n\nManufacturers and pharmaceutical companies in the cosmetics and skincare sectors should review the patent claims to assess potential impact on product development and freedom to operate. This is a routine patent publication creating no immediate compliance obligations. R&D teams may want to evaluate whether this intellectual property affects existing or planned formulations.

Source document (simplified)

← EPO Patent Bulletin

USE OF AN EXTRACT FROM LESPEDEZA PLANT AS ACTIVE INGREDIENT IN A COMPOSITION FOR INCREASING RADIANCE OF THE SKIN

Publication EP3681467A2 Kind: A2 Mar 25, 2026

Applicants

Clariant International Ltd

Inventors

YEOM, Mi Ji, JUNG, Eun Sun, PARK, Deok Hoon, FRECHET, Mathilde, CHAJRA, Hanane

IPC Classifications

A61K 8/9789 20170101AFI20200123BHEP A61K 36/185 20060101ALI20200123BHEP A61Q 19/08 20060101ALI20200123BHEP A61Q 19/00 20060101ALI20200123BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3681467A2

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent Protection Cosmetic Formulation
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal, Compliance
Topics
Pharmaceuticals Consumer Protection Healthcare

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.